Clinical Trials List
Protocol NumberWO46069
Not yet recruiting
2026-03-01 - 2032-12-31
Phase II/III
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- WEI-LI MA 無
- 陳怡君 無
- 楊明翰 無
- Wei-Wu Chen 無
- 李佳真 無
- 林柏翰 無
- 謝正彥 無
- 林季宏 無
- 羅喬 無
- MING-YANG WANG 無
- YEN-SHEN LU 無
- 黃柏翔 無
Co-Principal Investigator
Co-Principal Investigator
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
650 participants
